T Cell News and Research

Latest T Cell News and Research

SARS-CoV-2 RNA in blood tests not associated with infectious virus

The pandemic caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has challenged hospitals and laboratory services worldwide. Diagnostic testing for SARS-CoV-2 initially lagged but is now primarily based on the use of reverse transcriptase-polymerase chain reaction (RT-PCR) to detect viral nucleic RNA in the samples. However, viral RNA has also been reported in several small series of cases, though its significance and frequency remain unclear.

27 May 2020

Simple urine-testing method for people with kidney stones offers results in 30 minutes

An improved urine-testing system for people suffering from kidney stones inspired by nature and proposed by researchers from Penn State and Stanford University may enable patients to receive results within 30 minutes instead of the current turnaround time of a week or more.

27 May 2020

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Even as the COVID-19 pandemic continues to smolder and flare up in various parts of the world, researchers are still trying to make sense of the virus, its routes of spread, its target tissues, and the immune responses it induces. One crucial piece of knowledge is that the primary viral receptor is a human enzyme called angiotensin-converting enzyme 2 (ACE2).

27 May 2020

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

A recent paper by researchers from China demonstrated comparable expression levels of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) cell entry mediators in adults and children, suggesting that previously implied difference in viral-entry associated genes is likely not responsible for milder symptoms in children. The study is currently available on the medRxiv preprint server.

27 May 2020

Nimodipine-loaded biodegradable fibers to protect nerve cells after brain surgery

Brain surgery poses a major threat to nerve cells. Even slight injuries can kill the sensitive cells. The drug nimodipine could help prevent this.

27 May 2020

Mouse model mimics clinical course and pathology observed in COVID-19 patients

A mouse model of infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) reproduces features observed in human patients, researchers report May 26 in the journal Cell Host & Microbe.

27 May 2020

Emerging antiviral may turn the tide for COVID-19 pandemic

Scientists everywhere are working overtime to develop treatments for COVID-19, the disease caused by the novel coronavirus SARS-CoV-2.

27 May 2020

Researchers develop promising immunotherapy treatment for glioblastoma

Researchers of McMaster University and the University of Toronto have developed a promising immunotherapy treatment for a deadly form of adult brain cancer called glioblastoma.

27 May 2020

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Checkpoint inhibitors, a type of immunotherapy, that target myeloid immune cells and slow tumor growth were discovered by a team from the Perelman School of Medicine at the University of Pennsylvania and other institutions.

27 May 2020

Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma

The Ivy Brain Tumor Center at Barrow Neurological Institute announced that patient recruitment has opened for a new Phase 0 clinical trial to evaluate two targeted therapy drugs, abemaciclib and LY3214996.

27 May 2020

COVID-19 Rapid Research Fund allows coronavirus research in Ontario and London

Sepsis is a life-threatening condition. It occurs when the body's response to an infection is out of balance, triggering hyperinflammation that can damage multiple organs.

27 May 2020

Findings provide new insights into future cancer treatment

An early age of pregnancy (25 years and younger) is known to reduce the overall risk of breast cancer by over 30%. CSHL Assistant Professor Camila dos Santos spent several years teasing out the molecular details behind the protective effects of pregnancy.

27 May 2020

A new therapeutic approach to improve the health of diabetic patients

Scientists at Sanford Burnham Prebys Medical Discovery Institute have mapped for the first time the vast network of proteins that interact with proinsulin, the protein the body normally processes into insulin.

27 May 2020

Identifying the Starting Points for COVID19 Treatment

News-Medical spoke to researchers from the German Primate Center on their research in determining the activation sequence of the SARS-CoV-2 virus.

27 May 2020

CanSino's potential coronavirus vaccine triggers immune response in clinical trial

Scientists across the globe are racing to develop a vaccine that can provide protection against coronavirus disease (COVID-19). An effective and safe vaccine would curb not only the current coronavirus pandemic but also prevent future outbreaks

27 May 2020

New strategy identified to address the underlying cause of LAD1 patients' symptoms

Owing to a rare genetic mutation, individuals with leukocyte adhesion deficiency type 1 (LAD1) experience a suite of symptoms that trace back to an immune system dysfunction.

27 May 2020

WHO halts Hydroxychloroquine in COVID-19 trial over safety concerns

The coronavirus disease (COVID-19) has taken a toll on 188 countries and territories across the globe. With the increasing number of confirmed cases, scientists race to develop treatments and vaccines to fight the novel coronavirus.

27 May 2020

Blood clotting disorders may explain some of the worst symptoms of COVID-19

The hypothesis that blood clotting disorders may explain some of the worst symptoms of COVID-19, including respiratory failure and pulmonary fibrosis, was suggested in mid-April by researchers in Brazil affiliated with the University of São Paulo's Medical School (FM-USP) via an article accepted for publication by the Journal of Thrombosis.

27 May 2020

Updates on stem cell therapeutics and regenerative medicine

Stem cell and regenerative medicine research is an important area of clinical research which promises to change the face of medicine as it will be practiced in the years to come.

27 May 2020

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

A recent FDA approval supported by Stand Up To Cancer research provides a new treatment option for patients with an aggressive form of prostate cancer.

27 May 2020

T Cell News and Research

Latest T Cell News and Research

SARS-CoV-2 RNA in blood tests not associated with infectious virus

Simple urine-testing method for people with kidney stones offers results in 30 minutes

ACE2 receptors in the kidney not linked to high BP or RAS blockers

Study shows children and adults have a comparable expression of SARS-CoV-2 entry-related genes

Nimodipine-loaded biodegradable fibers to protect nerve cells after brain surgery

Mouse model mimics clinical course and pathology observed in COVID-19 patients

Emerging antiviral may turn the tide for COVID-19 pandemic

Researchers develop promising immunotherapy treatment for glioblastoma

Novel immunotherapy targeting myeloid immune cells reduces tumor growth

Ivy Center opens new clinical trial to evaluate experimental drug cocktail for glioblastoma

COVID-19 Rapid Research Fund allows coronavirus research in Ontario and London

Findings provide new insights into future cancer treatment

A new therapeutic approach to improve the health of diabetic patients

Identifying the Starting Points for COVID19 Treatment

CanSino's potential coronavirus vaccine triggers immune response in clinical trial

New strategy identified to address the underlying cause of LAD1 patients' symptoms

WHO halts Hydroxychloroquine in COVID-19 trial over safety concerns

Blood clotting disorders may explain some of the worst symptoms of COVID-19

Updates on stem cell therapeutics and regenerative medicine

Stand Up To Cancer hails FDA approval of new treatment option for aggressive prostate cancer

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Newsletters you may be interested in